| human | Q5 |
| P11673 | IRIS UNIROMA2 author ID | 09186 |
| P496 | ORCID iD | 0000-0002-3439-7750 |
| P1153 | Scopus author ID | 36061069200 |
| P735 | given name | Roberta | Q18194774 |
| Roberta | Q18194774 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | female | Q6581072 |
| Q53196471 | A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts. |
| Q91480628 | A national mandatory-split liver policy: A report from the Italian experience |
| Q102985546 | A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns |
| Q50059454 | Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients. |
| Q38567771 | Adult liver transplantation in the congenital absence of inferior vena cava. |
| Q91255991 | Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome |
| Q39398847 | Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature. |
| Q92350047 | Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? |
| Q55260952 | Donation after Circulatory Death in Paediatric Liver Transplantation: Current Status and Future Perspectives in the Machine Perfusion Era. |
| Q57792492 | Everolimus and Enteric-Coated Mycophenolate Sodium Ab Initio after Liver Transplantation: Midterm Results |
| Q47347380 | First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. |
| Q57791738 | Glycogen Storage Disease Type Ia and VI Associated With Hepatocellular Carcinoma: Two Case Reports |
| Q38053172 | Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation |
| Q58555478 | Hepatocellular carcinoma in children: hepatic resection and liver transplantation |
| Q49850094 | Higher Retransplantation rate following Extended Right Split-Liver Transplantation - An analysis from the Eurotransplant Liver follow-up Registry. |
| Q91094318 | How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature |
| Q34168552 | Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients |
| Q57792402 | Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study |
| Q35640630 | Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation |
| Q50880142 | Is routine hepaticojejunostomy at the time of unplanned surgical bypass required in the era of self-expanding metal stents? |
| Q53092955 | Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: report of a case. |
| Q90875752 | Life-saving vascular access after combined liver and kidney transplantation: A challenging access to the right atrium |
| Q43037581 | Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results |
| Q57791759 | Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C |
| Q57792542 | Management of Spermatic Cord Liposarcoma in Renal Transplant Recipients: Case Report |
| Q91640040 | Maple Syrup Urine Disease and Domino Liver Transplantation: When and How? |
| Q41705798 | One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial |
| Q51744352 | Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry. |
| Q39436989 | Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. |
| Q91097635 | Primary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplantation: A Single-Center Experience |
| Q51822089 | Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. |
| Q43037604 | Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. |
| Q52809394 | Severe unresolved cholestasis due to unknown aetiology leading to early allograft failure within the first 3 months of liver transplantation. |
| Q41980165 | Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis |
| Q43037553 | Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis |
| Q48352186 | Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. |
| Q57792530 | Switch from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Kidney Transplantation |
| Q91535384 | The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs |
| Q126088232 | The Role of Donor Gamma-Glutamyl Transferase as a Risk Factor for Early Graft Function after Liver Transplantation |
| Q44492999 | The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up |
| Q55033985 | The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy. |
| Q97430334 | The new horizon of split liver transplantation: ex situ liver splitting during hypothermic oxygenated machine perfusion |
| Q89641610 | Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection? |
Search more.